Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Surgutneftegaz earned ₽1.4 trillion in net profit

12/25/23 SNGS

Bank of Russia registered issues of shares in Yandex ICAO

12/25/23 YNDX

Nornickel's capex in 2024 will amount to $3.6 billion

12/25/23 GMKN

SGC will allocate an additional ₽1 billion to reduce debt

12/25/23 UGLD

SPB Exchange may be connected to cross-border settlements with cryptocurrency

12/25/23 SPBE

MTS may buy Mars Media Entertainment production center

12/25/23 MTSS

Henderson's LFL sales grew 27.3% in the January-November period

12/25/23 HNFG

Foreign shareholders of Arctic LNG-2 declared force majeure

12/25/23 NVTK

Tatneft shareholders failed to approve dividends

12/25/23 TATN

Rosbank will buy a portfolio of Russian public companies from Societe Generale

12/25/23 ROSB